TENON MEDICAL INC (TNON)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
$1.64-14.14%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · TNON
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 43 industry peers
TNON — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-09-16
Unregistered Sales of Equity Securities. The Company issued the New Warrants pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), available under Section 4(a)(2). Neither the issuance of the New Warrants nor the shares of Common Stock underlying the New Warrants have been registered under the Securities Act, and such securities may not be offered or sold in the United States absent registration or an exemption from regi…
Why it matters: More surgical cases can show whether expanded training and sales work are bringing in users. A drop would weaken that signal.
Supportive ifThe November 12 update says Q3 surgical case volume topped the July 2026 record.
Worry ifThe November 12 update reports Q3 case volume below the July 2026 record.
Why it matters: Revenue rose 127% year over year in Q2, and gross margin reached 64%. The next report tests whether that progress continued.
Supportive ifOn November 12, Q3 revenue is higher year over year and gross margin is at least 64%.
Worry ifOn November 12, Q3 revenue is flat or lower year over year, or gross margin falls below 43%.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$478 on $10,000 · ±4.8% | How much price usually moves either way. |
| Bad day | $1,334 loss on $10,000 · 13.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,637 loss on $10,000 · 96.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.